ARTICLE | Company News
FDA committee to discuss Northera
December 30, 2011 1:31 AM UTC
FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Feb. 23 to discuss an NDA from Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) for Northera droxidopa to treat symptomatic ne...